Compare peptides
Head-to-head comparisons grounded in trial data where it exists. We flag when a comparison rests on preclinical evidence only.
Molecular formulae and 3D structures are sourced from PubChem (each viewer links its CID) and cross-checked against the known peptide formula — nothing is estimated. Large peptides have no published 3D conformer, so their real 2D structure is shown and labelled as such; mixtures and compounds with no single PubChem record are left blank rather than fabricated. Evidence tiers are inferred from regulatory status and are not a measure of safety.
In-depth written comparisons
Long-form, sourced analyses for the most-searched pairings.
A side-by-side of two approved incretin medicines, grounded in head-to-head trial data (SURPASS-2) and their respective phase-3 weight-management programs.
Two research-only recovery peptides compared on mechanism and evidence base.
Two growth-hormone secretagogues compared.
A GHRH analog compared with an approved one.
Two melanocortin agonists compared, with safety context.
Two growth-hormone-releasing peptides compared.
Two nootropic research peptides compared.